Pharmacogenomic and Response-Guided Treatment of Infectious Disease Using Yeast-Based Immunotherapy

摘要

Disclosed are improved methods for treating an infectious disease with yeast-based immunotherapy, including viral disease, such as disease resulting from hepatitis virus infection, using a pharmacogenomic and response-guided approach based on IL28B genotype of the individual.